Genomic Opioid Optimization of Dosing and Selections (GOODS) Study
NCT03579121
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
76
Enrollment
OTHER
Sponsor class
Conditions
Perioperative/Postoperative Complications
Interventions
OTHER:
Pharmacogenomic (PGx)
OTHER:
Review results
Sponsor
Mayo Clinic